Wagner Heidi L
SEC Form 4 insider trading activity
Wagner Heidi L has filed 2 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Aug 14, 2026.
On the most recent filing, Wagner Heidi L is listed as Director at Wave Life Sciences, Inc. Inside the rolling window, Wagner Heidi L reported no open-market purchases and 2 open-market sales totaling $231K in WVE. The largest disclosed transaction in the window is a sale of 14,000 WVE shares on Dec 8, 2025, worth $189K.
Companies traded
Other insiders at WVE
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$231K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Wagner Heidi L made?
Wagner Heidi L has filed 2 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.
Which companies does Wagner Heidi L trade?
Wagner Heidi L has filed SEC Form 4 disclosures for 1 company, including WVE.
When was Wagner Heidi L's most recent SEC Form 4 filing?
Wagner Heidi L's most recent SEC Form 4 filing on Tracefour is dated Aug 14, 2026.
What is Wagner Heidi L's total buy and sell value in the current window?
Inside the rolling retention window, Wagner Heidi L bought $0 and sold $231K based on SEC Form 4 filings.
What was Wagner Heidi L's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 14,000 WVE shares on 2025-12-08, worth $189K, per SEC Form 4 filings.